Innovent Biologics Technology Limited (shanghai R&d Center)

This early-phase study tested the safety and how the body processes a single dose of IBI3032 in 40 healthy adults. Participants were randomly assigned to receive either the drug or a placebo, and some took it with or without food to see if meals affect absorption. The goal was to…